The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,937
Sort by:
Chronic Immune Thrombocytopenia Market - 2026-2033
US$ 3,400.00
The Chronic Immune Thrombocytopenia Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
April 2026
57 pages
Cri-du-chat Syndrome Market - 2026-2033
US$ 3,400.00
Cri-du-chat Syndrome Market reached USD 1.37 Billion in 2025 and is expected to reach USD 3.90 billion by 2033, growing with a CAGR of 14.03% during the forecast period 2026-2033. The Cri-du-chat Synd...
April 2026
46 pages
Gastrointestinal Therapeutics Market - 2026-2033
US$ 3,400.00
Gastrointestinal Therapeutics Market reached USD 66.25 billion in 2025 and is expected to reach USD 106.78 billion by 2033, growing with a CAGR of 6.42% during the forecast period 2026-2033. The Gastr...
April 2026
55 pages
Gout Therapeutics Market - 2026-2033
US$ 3,400.00
Gout Therapeutics Marketis is growing with a CAGR of 7.40% during the forecast period 2026-2035. The Gout Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
April 2026
43 pages
Growth Hormone Deficiency Treatment Market - 2026-2033
US$ 3,400.00
Growth Hormone Deficiency Treatment Market reached US$ 7.74 billion in 2025 and is expected to reach US$ 19.3 billion by 2033, growing with a CAGR of 12.10% during the forecast period 2026-2033. The G...
April 2026
61 pages
Periodontal Therapeutics Market - 2026-2033
US$ 3,400.00
Periodontal Therapeutics Marketis is growing with a CAGR of 7.20% during the forecast period 2026-2035. The Periodontal Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth...
April 2026
50 pages
Thyroid Gland Disorders Therapeutics Market - 2026-2033
US$ 3,400.00
Thyroid Gland Disorders Therapeutics Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The Thyroid Gland Disorders Therapeutics Market emerges as a key focus in DataM Inte...
April 2026
62 pages
Seed Treatment Market - 2026-2033
US$ 3,400.00
Seed Treatment Market reached USD 7,922 million in 2025 and is expected to reach USD 16,101 million by 2033, growing with a CAGR of 8.10% during the forecast period 2026-2033. The Seed Treatment Marke...
April 2026
40 pages
Water for Injection Market - 2026-2033
US$ 3,400.00
Water for Injection Market reached US$ 32.94 Billion in 2025 and is expected to reach US$ 60.97 Billion by 2033, growing with a CAGR of 8.00% during the forecast period 2026-2033. The Water for Inject...
April 2026
45 pages
Local Anesthesia Drugs Market - 2026-2033
US$ 3,400.00
Local Anesthesia Drugs Marketis is growing with a CAGR of 6.30% during the forecast period 2026-2035. The Local Anesthesia Drugs Market emerges as a key focus in DataM Intelligence latest in-depth ana...
April 2026
48 pages
Global Phenylketonuria Treatment Market - 2026-2033
US$ 3,400.00
Global Phenylketonuria Treatment Marketis is growing with a CAGR of 8.40% during the forecast period 2026-2035. The Global Phenylketonuria Treatment Market emerges as a key focus in DataM Intelligence...
April 2026
58 pages
Appetite Stimulant Market Size, Share & Trends Analysis Report By Pharmacological Class (Cannabinoids & CNS-Acting Agents, Anabolic & Metabolic Agents), By Indication, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global appetite stimulant market size was estimated at USD 1.73 billion in 2025 and is projected to reach USD 2.90 billion by 2033, growing at a CAGR of 6.76% from 2026 to 2033. The market address...
April 2026
150 pages
Weight loss therapeutics Market - 2026-2033
US$ 3,400.00
Weight loss therapeutics Marketis is growing with a CAGR of 20.60% during the forecast period 2026-2035. The Weight loss therapeutics Market emerges as a key focus in DataM Intelligence latest in-dept...
April 2026
50 pages
Global Rare Disease Therapeutics Market - 2025-2033
US$ 3,400.00
Global Rare Disease Therapeutics Market reached US$ 135.88 billion in 2023 and is expected to reach US$ 495.27 billion by 2033, growing with a CAGR of 13.80% during the forecast period 2026-2033. The...
April 2026
58 pages
Solid Dosage Form Market Forecasts to 2034 – Global Analysis By Dosage Form (Tablets, Capsules, Powders & Granules, Lozenges & Pastilles, Pellets & Mini-Tablets, Orally Disintegrating Films, and Other Dosage Forms), Drug Release, Route of Administration, Therapeutic Area, Manufacturing Process, Drug Type, Patient Demographics, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Solid Dosage Form Market is accounted for $1113.6 billion in 2026 and is expected to reach $1856.9 billion by 2034 growing at a CAGR of 6.6% during the forecas...
April 2026
200 pages
Congenital Adrenal Hyperplasia Treatment Market - 2026-2033
US$ 3,400.00
Congenital Adrenal Hyperplasia Treatment Market reached US$ 0.27 billion in 2025 and, growing with a CAGR of 6.60% during the forecast period 2025-2035. The Congenital Adrenal Hyperplasia Treatment Ma...
April 2026
66 pages
Congenital Hyperinsulinism Treatment Market - 2026-2033
US$ 3,400.00
Congenital Hyperinsulinism Treatment Market reached USD 171.9 million in 2025 and is expected to reach USD 263.9 million by 2033, growing with a CAGR of 5.50% during the forecast period 2026-2033. The...
April 2026
62 pages
Circadian Rhythm Sleep Treatment Market - 2026-2033
US$ 3,400.00
Circadian Rhythm Sleep Treatment Market reached USD 104.5 million in 2025 and, growing with a CAGR of 4.50% during the forecast period 2025-2035. The Circadian Rhythm Sleep Treatment Market emerges a...
April 2026
59 pages
Opioid Induced Constipation Treatment Market - 2026-2033
US$ 3,400.00
Opioid Induced Constipation Treatment Market reached US$ 1,241.90 million in 2025 and is expected to reach US$ 1,835.00 million by 2033, growing with a CAGR of 5.00% during the forecast period 2026-20...
April 2026
63 pages
Global Eletriptan Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... are 15 Chapters to deeply display the global Eletriptan market. Chapter 1, to describe Eletriptan Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the ...
April 2026
88 pages
Global Vinca Alkaloid API Market Growth 2026-2032
US$ 3,660.00
The global Vinca Alkaloid API market size is predicted to grow from US$ 130 million in 2025 to US$ 214 million in 2032; it is expected to grow at a CAGR of 7.5% from 2026 to 2032. Vinca alkaloids are...
April 2026
116 pages
Global Pharma Grade Ethyl Oleate Market Growth 2026-2032
US$ 3,660.00
The global Pharma Grade Ethyl Oleate market size is predicted to grow from US$ 40.46 million in 2025 to US$ 62.09 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032. Ethyl Ole...
April 2026
104 pages
Global Polypeptide API Market Growth 2026-2032
US$ 3,660.00
The global Polypeptide API market size is predicted to grow from US$ 8387 million in 2025 to US$ 15420 million in 2032; it is expected to grow at a CAGR of 9.3% from 2026 to 2032. Polypeptide API is t...
April 2026
134 pages
Global Pharma Grade Zein Market Growth 2026-2032
US$ 3,660.00
The global Pharma Grade Zein market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Pharma G...
April 2026
84 pages
Global GLP-1 Drug Peptide API Market Growth 2026-2032
US$ 3,660.00
The global GLP-1 Drug Peptide API market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. GLP-1 (Glucagon-Like Peptide...
April 2026
95 pages
Global Triptans Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Triptans market size is expected to reach $ 1663 million by 2032, rising at a market growth of 3.8% CAGR during the forecast period (2026-2032). Triptans are a class of selective 5-HT1B/1D...
April 2026
195 pages
Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size, Share & Trends Analysis Report By Action of Mechanism (Complement Inhibitors, Supportive Care, Others), By Route of Administration, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The Japan paroxysmal nocturnal hemoglobinuria treatment market size was valued at USD 279.95 million in 2025 and is projected to reach USD 455.53 million by 2033, growing at a CAGR of 5.88% from 2026...
April 2026
150 pages
